CORC

浏览/检索结果: 共63条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Shen, Xia-Bo;  Li, Guang-Liang;  Zheng, Ya-Bing;  Chen, Zhan-Hong;  Cao, Wen-Ming
收藏  |  浏览/下载:23/0  |  提交时间:2021/11/01
Exploring the concepts and practices of advanced breast cancer treatment: a narrative review 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Wang, Xiaojia;  Shao, Xiying;  Huang, Jian;  Lei, Lei;  Huang, Yuan
收藏  |  浏览/下载:39/0  |  提交时间:2021/06/15
Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Shao, Xiying;  Zheng, Yabing;  Cao, Wenming;  Shen, Xiabo;  Li, Guangliang
收藏  |  浏览/下载:52/0  |  提交时间:2021/06/15
The outcome of patients with metastatic breast cancer with lung metastasis treated with fulvestrant is superior to that of those with liver metastasis 会议论文
作者:  He, M.;  Li, J-J.;  Zuo, W-J.;  Ji, L.;  Hu, X-C.
收藏  |  浏览/下载:14/0  |  提交时间:2019/12/05
Monitoring the Early Response of Fulvestrant Plus Tanshinone IIA Combination Therapy to Estrogen Receptor-Positive Breast Cancer by Longitudinal F-18-FES PET/CT 期刊论文
CONTRAST MEDIA & MOLECULAR IMAGING, 2019
作者:  Zhang, YingJian;  Luo, JianMin;  Zhang, YongPing;  Wang, MingWei;  He, SiMin
收藏  |  浏览/下载:33/0  |  提交时间:2019/12/05
Visceral metastases should distinguish between liver or lung when treating HR-positive/HER2-negative advanced breast cancer with fulvestrant 会议论文
作者:  He, M.;  Li, J. -J.;  Zuo, W. -J.;  Wang, Z. -H.;  Shao, Z. -M.
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/05
Treatment after Progression on Fulvestrant among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study 期刊论文
SCIENTIFIC REPORTS, 2019, 卷号: 9
作者:  Xie, Yizhao;  Zhao, Yannan;  Gong, Chengcheng;  Chen, Zhanhong;  Zhang, Yinbin
收藏  |  浏览/下载:20/0  |  提交时间:2019/12/05
Neddylation Inactivation Facilitates FOXO3a Nuclear Export to Suppress Estrogen Receptor Transcription and Improve Fulvestrant Sensitivity 期刊论文
CLINICAL CANCER RESEARCH, 2019, 卷号: 25, 期号: 12
作者:  Jia, Xiaoqing;  Li, Chunjie;  Li, Lihui;  Liu, Xiaoli;  Zhou, Lisha
收藏  |  浏览/下载:37/0  |  提交时间:2019/12/05
Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study 期刊论文
CLINICAL BREAST CANCER, 2019, 卷号: 19, 期号: 3
作者:  Xie, Yizhao;  Li, Yi;  Zhang, Yinbin;  Zhang, Shuqun;  Li, Wei
收藏  |  浏览/下载:26/0  |  提交时间:2019/12/05
The outcome of lung metastasis treated with fulvestrant is superior to that of liver metastasis for metastatic breast cancer 会议论文
作者:  He, M.;  Li, J-J;  Zuo, W-J;  Ji, L.;  Hu, X-C
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace